Cargando…

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic

Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease course. This longitudinal, prospective, multi-centre-study of G...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidler, Felicita, Baldt, Julia, Frahm, Niklas, Langhorst, Silvan Elias, Mashhadiakbar, Pegah, Streckenbach, Barbara, Burian, Katja, Zettl, Uwe Klaus, Richter, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449937/
https://www.ncbi.nlm.nih.gov/pubmed/36071083
http://dx.doi.org/10.1038/s41598-022-18912-3
_version_ 1784784411825274880
author Heidler, Felicita
Baldt, Julia
Frahm, Niklas
Langhorst, Silvan Elias
Mashhadiakbar, Pegah
Streckenbach, Barbara
Burian, Katja
Zettl, Uwe Klaus
Richter, Jörg
author_facet Heidler, Felicita
Baldt, Julia
Frahm, Niklas
Langhorst, Silvan Elias
Mashhadiakbar, Pegah
Streckenbach, Barbara
Burian, Katja
Zettl, Uwe Klaus
Richter, Jörg
author_sort Heidler, Felicita
collection PubMed
description Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease course. This longitudinal, prospective, multi-centre-study of German MS-patients aimed to detect socio-demographic, clinical, or psychological determinants of attitudes towards standard vaccines, SARS-CoV-2 vaccines, and governmental measures before/during the pandemic. Exactly 404 MS-patients were investigated by standardized questionnaires and structured interviews on socio-demographic, clinical-neurological, and psychological characteristics, vaccination status, and vaccination from June 2019. Data on SARS-CoV-2 vaccination willingness were collected in two follow-up assessments (1st: June to July 2020, before SARS-CoV-2 vaccine availability, N = 200; 2nd: March to May 2021, after SARS-CoV-2 vaccine availability, N = 157). Age, sex, MS course type, depression, and personality characteristics (Extraversion, Novelty seeking, Self-directedness, and Cooperativeness) were significantly associated with vaccination willingness. Although the majority of MS-patients showed SARS-CoV-2 vaccination willingness at both follow-ups (1st: 60%, 2nd: 61%), a substantial proportion had concerns and were undecided or opposed to vaccination. Socio-demographic variables like age and sex, psychopathological status, and various personality characteristics might influence vaccination willingness and should be considered when discussing with MS-patients about SARS-CoV-2 vaccination.
format Online
Article
Text
id pubmed-9449937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94499372022-09-07 Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic Heidler, Felicita Baldt, Julia Frahm, Niklas Langhorst, Silvan Elias Mashhadiakbar, Pegah Streckenbach, Barbara Burian, Katja Zettl, Uwe Klaus Richter, Jörg Sci Rep Article Vaccination is a key strategy for controlling the SARS-CoV-2 pandemic. Acceptance of SARS-CoV-2 vaccines by chronically ill patients, such as multiple sclerosis (MS) patients, plays an important role in prevention of complicated disease course. This longitudinal, prospective, multi-centre-study of German MS-patients aimed to detect socio-demographic, clinical, or psychological determinants of attitudes towards standard vaccines, SARS-CoV-2 vaccines, and governmental measures before/during the pandemic. Exactly 404 MS-patients were investigated by standardized questionnaires and structured interviews on socio-demographic, clinical-neurological, and psychological characteristics, vaccination status, and vaccination from June 2019. Data on SARS-CoV-2 vaccination willingness were collected in two follow-up assessments (1st: June to July 2020, before SARS-CoV-2 vaccine availability, N = 200; 2nd: March to May 2021, after SARS-CoV-2 vaccine availability, N = 157). Age, sex, MS course type, depression, and personality characteristics (Extraversion, Novelty seeking, Self-directedness, and Cooperativeness) were significantly associated with vaccination willingness. Although the majority of MS-patients showed SARS-CoV-2 vaccination willingness at both follow-ups (1st: 60%, 2nd: 61%), a substantial proportion had concerns and were undecided or opposed to vaccination. Socio-demographic variables like age and sex, psychopathological status, and various personality characteristics might influence vaccination willingness and should be considered when discussing with MS-patients about SARS-CoV-2 vaccination. Nature Publishing Group UK 2022-09-07 /pmc/articles/PMC9449937/ /pubmed/36071083 http://dx.doi.org/10.1038/s41598-022-18912-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Heidler, Felicita
Baldt, Julia
Frahm, Niklas
Langhorst, Silvan Elias
Mashhadiakbar, Pegah
Streckenbach, Barbara
Burian, Katja
Zettl, Uwe Klaus
Richter, Jörg
Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
title Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
title_full Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
title_fullStr Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
title_full_unstemmed Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
title_short Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
title_sort vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of sars-cov-2 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449937/
https://www.ncbi.nlm.nih.gov/pubmed/36071083
http://dx.doi.org/10.1038/s41598-022-18912-3
work_keys_str_mv AT heidlerfelicita vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT baldtjulia vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT frahmniklas vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT langhorstsilvanelias vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT mashhadiakbarpegah vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT streckenbachbarbara vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT buriankatja vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT zettluweklaus vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic
AT richterjorg vaccinationwillingnessinassociationwithpersonalitytraitsinpatientswithmultiplesclerosisinthecourseofsarscov2pandemic